Literature DB >> 6499113

32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.

D H Phillips, M V Reddy, K Randerath.   

Abstract

When a series of nine alkenylbenzenes were administered to preweanling male mice, safrole, estragole and methyleugenol induced a significant incidence of hepatic carcinomas, while eugenol, anethole, elemicin, myristicin, dill apiol and parsley apiol did not (Miller et al., Cancer Res., 43, 1124-1134, 1983). Following the protocol used to test seven of these compounds, male C57Bl X C3H/He F1 mice were injected with 0.25, 0.5, 1.0 and 3.0 mumol of a compound on days 1, 8, 15 and 22 after birth, respectively. Groups of mice were killed and their liver DNA isolated on days 23, 29 and 43, and analysed by a modified 32P-post-labelling procedure. Highest levels of adducts were detected with methyleugenol (72.7 pmol/mg DNA), estragole (30.0) and safrole (17.5). After correction for liver growth it was estimated that most of these adducts were still present at 43 days. Significant levels of DNA binding by myristicin (7.8 pmol/mg DNA) and elemicin (3.7) were also found but in the former case the adducts were less persistent. Only low levels of adducts were detected with anethole, dill apiol and parsley apiol (less than 1.4 pmol/mg DNA); no DNA binding was detected with eugenol. Thus, all but one of the alkenylbenzenes studied became bound to newborn mouse-liver DNA, but the levels and the persistence of adducts formed by the carcinogenic compounds were greater.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499113     DOI: 10.1093/carcin/5.12.1623

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

1.  The influence of the SULT1A status - wild-type, knockout or humanized - on the DNA adduct formation by methyleugenol in extrahepatic tissues of mice.

Authors:  K Herrmann; W Engst; S Florian; A Lampen; W Meinl; H R Glatt
Journal:  Toxicol Res (Camb)       Date:  2016-02-12       Impact factor: 3.524

Review 2.  Estimation of exposure of man to substances reacting covalently with macromolecules.

Authors:  P B Farmer; H G Neumann; D Henschler
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

Review 3.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

Review 4.  DNA adducts in experimental cancer research.

Authors:  K Hemminki; A Försti; R Mustonen; K Savela
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Study of the Anti-Proliferative Activity of 5-Substituted 4,7-Dimethoxy-1,3-Benzodioxole Derivatives of SY-1 from Antrodia camphorata on Human COLO 205 Colon Cancer Cells.

Authors:  Hsiu-Man Lien; Po-Tsun Kuo; Chao-Lu Huang; Jung-Yie Kao; Ho Lin; Ding-Yah Yang; Ya-Yun Lai
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-03       Impact factor: 2.629

6.  32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.

Authors:  M V Reddy; K Randerath
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

7.  Postlabeling methods for carcinogen-DNA adduct analysis.

Authors:  K Randerath; E Randerath; H P Agrawal; R C Gupta; M E Schurdak; M V Reddy
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

8.  Methyl Chavicol and Its Synthetic Analogue as Possible Antioxidant and Antilipase Agents Based on the In Vitro and In Silico Assays.

Authors:  Bruna Celeida Silva Santos; Andressa Soares Pires; Célia Hitomi Yamamoto; Mara Rubia Costa Couri; Alex Gutterres Taranto; Maria Silvana Alves; Ana Lúcia Dos Santos de Matos Araújo; Orlando Vieira de Sousa
Journal:  Oxid Med Cell Longev       Date:  2018-04-11       Impact factor: 6.543

9.  Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.

Authors:  Ans Punt; Alicia Paini; Marelle G Boersma; Andreas P Freidig; Thierry Delatour; Gabriele Scholz; Benoît Schilter; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Toxicol Sci       Date:  2009-05-15       Impact factor: 4.849

10.  Physiologically based kinetic modeling of the bioactivation of myristicin.

Authors:  Amer J Al-Malahmeh; Abdelmajeed Al-Ajlouni; Sebastiaan Wesseling; Ans E M F Soffers; Ala' Al-Subeihi; Reiko Kiwamoto; Jacques Vervoort; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2016-06-22       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.